Wangang Guo

521 total citations
21 papers, 397 citations indexed

About

Wangang Guo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Wangang Guo has authored 21 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Wangang Guo's work include Signaling Pathways in Disease (4 papers), Cardiac Fibrosis and Remodeling (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Wangang Guo is often cited by papers focused on Signaling Pathways in Disease (4 papers), Cardiac Fibrosis and Remodeling (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Wangang Guo collaborates with scholars based in China, Australia and Poland. Wangang Guo's co-authors include Qiangsun Zheng, Yuerong Xu, Yan Li, Mingming Zhang, Haiyan Wang, Zifan Lu, Cheng Lian, Heng Ma, Fujun Shang and Wei Li and has published in prestigious journals such as PLoS ONE, Journal of Cellular Physiology and Journal of Molecular and Cellular Cardiology.

In The Last Decade

Wangang Guo

20 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangang Guo China 10 263 119 79 66 37 21 397
Qi Ma China 10 186 0.7× 96 0.8× 66 0.8× 50 0.8× 56 1.5× 32 467
Jin Wei China 9 253 1.0× 46 0.4× 105 1.3× 83 1.3× 33 0.9× 16 434
Jiayu Jin China 8 321 1.2× 71 0.6× 52 0.7× 72 1.1× 39 1.1× 12 463
Chuanshi Xiao China 11 166 0.6× 80 0.7× 77 1.0× 96 1.5× 64 1.7× 24 390
Shiqun Sun China 13 288 1.1× 78 0.7× 104 1.3× 144 2.2× 46 1.2× 34 559
Zhimei Lv China 12 234 0.9× 73 0.6× 30 0.4× 55 0.8× 46 1.2× 15 460
Wanwen Cheng China 8 193 0.7× 58 0.5× 120 1.5× 42 0.6× 30 0.8× 11 361
Xiaolei Bi China 8 175 0.7× 43 0.4× 80 1.0× 99 1.5× 51 1.4× 11 375
Xiyun Bian China 13 280 1.1× 54 0.5× 73 0.9× 82 1.2× 33 0.9× 29 472
Jiang Shi-sen China 11 140 0.5× 54 0.5× 83 1.1× 59 0.9× 77 2.1× 29 359

Countries citing papers authored by Wangang Guo

Since Specialization
Citations

This map shows the geographic impact of Wangang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangang Guo more than expected).

Fields of papers citing papers by Wangang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangang Guo. The network helps show where Wangang Guo may publish in the future.

Co-authorship network of co-authors of Wangang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wangang Guo. A scholar is included among the top collaborators of Wangang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangang Guo. Wangang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hao, et al.. (2024). Review of Progress in Interventional Therapy for Coronary Bifurcation Lesions. Reviews in Cardiovascular Medicine. 25(1). 2–2.
2.
Liu, Hao, et al.. (2024). Comparison of Postoperative Outcomes between Leadless and Conventional Transvenous Pacemakers Implantation: An Up-to-Date Meta-analysis. Reviews in Cardiovascular Medicine. 25(10). 359–359. 1 indexed citations
3.
Liu, Hao, et al.. (2023). Review of Techniques for Protecting Side Branch from Occlusion during Provisional Stenting in Coronary Bifurcation Lesions. Reviews in Cardiovascular Medicine. 24(11). 323–323. 1 indexed citations
4.
Wang, Ying, Yuerong Xu, Wangang Guo, et al.. (2022). Ablation of Shank3 alleviates cardiac dysfunction in aging mice by promoting CaMKII activation and Parkin-mediated mitophagy. Redox Biology. 58. 102537–102537. 25 indexed citations
5.
Cai, Wenbin, Yi Wang, Jia Wang, et al.. (2022). Preliminary study of carotid variables under ultrasound analysis as predictors for the risk of coronary arterial atherosclerosis. Echocardiography. 39(8). 1054–1063. 4 indexed citations
6.
Xu, Yuerong, Wangang Guo, Di Zeng, et al.. (2021). Inhibiting miR‐205 Alleviates Cardiac Ischemia/Reperfusion Injury by Regulating Oxidative Stress, Mitochondrial Function, and Apoptosis. Oxidative Medicine and Cellular Longevity. 2021(1). 9986506–9986506. 17 indexed citations
7.
Wang, Runze, Yuerong Xu, Fangfang Wang, et al.. (2021). Pathogenetic mechanisms of septic cardiomyopathy. Journal of Cellular Physiology. 237(1). 49–58. 62 indexed citations
8.
Guo, Wangang, et al.. (2020). Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2020. 1–15. 54 indexed citations
9.
Guo, Wangang, et al.. (2015). An Experimental Study to Determine the Role of Inferior Vena Cava Filter in Preventing Bone Cement Implantation Syndrome. Iranian Journal of Radiology. 12(3). e14142–e14142. 6 indexed citations
10.
Guo, Wangang, et al.. (2014). QKI deficiency promotes FoxO1 mediated nitrosative stress and endoplasmic reticulum stress contributing to increased vulnerability to ischemic injury in diabetic heart. Journal of Molecular and Cellular Cardiology. 75. 131–140. 52 indexed citations
11.
12.
Zeng, Di, Yan Jin, Xiongtao Liu, et al.. (2013). The Long-Term Differentiation of Embryonic Stem Cells into Cardiomyocytes: An Indirect Co-Culture Model. PLoS ONE. 8(1). e55233–e55233. 13 indexed citations
13.
Lu, Xiaozhao, Kai Chen, Hongliang Liang, et al.. (2013). Thyroid hormone inhibits TGFβ1 induced renal tubular epithelial to mesenchymal transition by increasing miR34a expression. Cellular Signalling. 25(10). 1949–1954. 18 indexed citations
14.
Su, Feifei, Wangang Guo, Xiongtao Liu, et al.. (2012). High-Mobility Group Box 1 Induces Calcineurin-Mediated Cell Hypertrophy in Neonatal Rat Ventricular Myocytes. Mediators of Inflammation. 2012. 1–9. 27 indexed citations
15.
Guo, Wangang, Xiaoqin Shi, Anheng Liu, et al.. (2011). RNA Binding Protein QKI Inhibits the Ischemia/reperfusion-induced Apoptosis in Neonatal Cardiomyocytes. Cellular Physiology and Biochemistry. 28(4). 593–602. 38 indexed citations
16.
Xie, Man‐Jiang, Hui Chang, Lin Zhang, et al.. (2010). Evidence that apoptotic signalling in hypertrophic cardiomyocytes is determined by mitochondrial pathways involving protein kinase Cδ. Clinical and Experimental Pharmacology and Physiology. 37(12). 1120–1128. 9 indexed citations
17.
Shi, Xiaoqin, Wangang Guo, & Na Peng. (2009). Prevention of bone cement implantation syndrome by inferior vena cava filter. Zhonghua chuangshang guke zazhi. 11(3). 255–258. 1 indexed citations
18.
Guo, Wangang, Feifei Su, Lijun Yuan, et al.. (2009). Simvastatin inhibits angiotensin II‐induced cardiac cell hypertrophy: Role of Homer 1a. Clinical and Experimental Pharmacology and Physiology. 37(1). 40–45. 8 indexed citations
19.
Liu, Xiongtao, Jian Yang, Fujun Shang, et al.. (2008). Silencing GIRK4 expression in human atrial myocytes by adenovirus-delivered small hairpin RNA. Molecular Biology Reports. 36(6). 1345–1352. 9 indexed citations
20.
Guo, Wangang, Zhi‐Bin Yu, & Man‐Jiang Xie. (2006). [Protein kinase Cdelta is possibly involved in the transition from hypertrophy to apoptosis of myocardiocytes].. PubMed. 58(3). 269–74. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qi Ma Breakdown of academic impact, for papers by Jin Wei Breakdown of academic impact, for papers by Jiayu Jin Breakdown of academic impact, for papers by Chuanshi Xiao Breakdown of academic impact, for papers by Shiqun Sun Breakdown of academic impact, for papers by Zhimei Lv Breakdown of academic impact, for papers by Wanwen Cheng Breakdown of academic impact, for papers by Xiaolei Bi Breakdown of academic impact, for papers by Xiyun Bian Breakdown of academic impact, for papers by Jiang Shi-sen
Rankless by CCL
2026